Related Experiment Video
Updated: Oct 2, 2025
Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6
Marlene Vierthaler1,2,3,4, Qian Sun1,2,3,4, Yiman Wang1,2,3,4
1Skin Cancer Unit, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Background:
ADCK2 is a member of the AarF domain-containing kinase family, which consists of five members, and has been shown to play a role in CoQ metabolism. However, ADCKs have also been connected to cancer cell survival, proliferation and motility. In this study, we investigated the role of ADCK2 in melanoma.
Methods:
The effect of ADCK2 on melanoma cell motility was evaluated by a scratch assay and a transwell invasion assay upon siRNA-mediated knockdown or stable overexpression of ADCK2.
Results:
We found that high levels of intratumoral ADCK2 and MYL6 are associated with a higher survival rate in melanoma patients. Knocking down ADCK2 resulted in enhanced cell migration of melanoma cells. Moreover, ADCK2-knockdown cells adopted a more dedifferentiated phenotype. A gene expression array revealed that the expression of ADCK2 correlated with the expressions of MYL6 and RAB2A. Knocking down MYL6 in ADCK2-overexpressing cells could abrogate the effect of ADCK2 overexpression and thus confirm the functional connection between ADCK2 and MYL6.
Conclusion:
ADCK2 affects melanoma cell motility, most probably via MYL6. Our results allow the conclusion that ADCK2 could act as a tumor suppressor in melanoma.
Insights
AarF domain-containing kinase 2 (ADCK2) acts as a tumor suppressor in melanoma by inhibiting cell motility, likely through MYL6. Higher ADCK2 levels correlate with better patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- ADCK2, a member of the AarF domain-containing kinase family, is implicated in CoQ metabolism and cancer progression.
- Previous studies link ADCK family members to cancer cell survival, proliferation, and motility.
Purpose of the Study:
- To investigate the specific role of ADCK2 in melanoma.
- To elucidate the molecular mechanisms underlying ADCK2's function in melanoma cells.
Main Methods:
- Melanoma cell motility was assessed using scratch and transwell invasion assays.
- ADCK2 function was studied via siRNA-mediated knockdown and stable overexpression.
- Gene expression analysis was performed using a gene expression array.
Main Results:
- High intratumoral ADCK2 levels correlate with improved melanoma patient survival.
- ADCK2 knockdown enhanced melanoma cell migration and promoted a dedifferentiated phenotype.
- ADCK2 expression positively correlated with MYL6 and RAB2A expression.
Conclusions:
- ADCK2 influences melanoma cell motility, potentially via MYL6.
- ADCK2 functions as a tumor suppressor in melanoma.
Related Concept Videos
01:35Cancer Cell Migration through Invadopodia
01:19Cell Migration
01:18Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....